Check out the latest news and insights from DrugDev

Ibraheem (Ibs) MahmoodJoin DrugDev President & CEO Ibraheem (Ibs) Mahmood and Melissa (Liss) Easy,  Founder of DrugDev and President of Site Identification and Activation for lunch Wednesday, February 24 at SCOPE for a preview of DrugDev’s exciting new Site Activation Module. Finding the right sites for your trial is challenging enough. Once identified, you need to get them activated quickly so that they can start enrolling patients.

Thanks to new technology including an innovative site activation module on the DrugDev platform (introduced Wednesday at SCOPE!), the days of relying on e-mail, manual spreadsheets, and hundreds of man hours to manage site activation are long behind us.

Join us for lunch and an exclusive sneak preview of an exciting technology solution – built on years of proven best practices – that will enable you to automate your site activation process, and provide your global sites with an efficient, reliable, and standardized activation experience.